Steroid hormone receptor expression and function in microglia

GLIA - Tập 56 Số 6 - Trang 659-674 - 2008
Amanda Sierra1,2, Andres Gottfried‐Blackmore1,2, Teresa A. Milner3,2, Bruce S. McEwen2, Karen Bulloch4
1AS and ACG are equal contributors to this study.
2Laboratory of Neuroendocrinology, Rockefeller University, New York, New York
3Division of Neurobiology, Department of Neurology and Neuroscience, Weill Cornell Medical College, New York, New York
4Laboratory of Cell Physiology and Immunology, Rockefeller University, New York, New York

Tóm tắt

AbstractSteroid hormones such as glucocorticoids and estrogens are well‐known regulators of peripheral immune responses and also show anti‐inflammatory properties in the brain. However, the expression of steroid hormone receptors in microglia, the pivotal immune cell that coordinates the brain inflammatory response, is still controversial. Here we use real time RT‐PCR to show that microglia, isolated from adult fms‐EGFP mice by FACS, express glucocorticoid receptor (GR), mineralocorticoid receptor (MR), and estrogen receptor alpha (ERα). GR was the most abundant steroid hormone receptor transcript in microglia. The presence of GR and ERα immunoreactivity was further confirmed in vivo at the ultrastructural level. To understand the role of steroid hormone receptors during the inflammation process, we evaluated the expression of steroid hormone receptors after inflammatory challenge and found a significant down‐regulation of GR, MR, and ERα in microglia. Finally, we tested the immunomodulatory properties of estrogens and glucocorticoids. Estradiol benzoate did not have any significant impact on the inflammatory profile of ex vivo sorted microglia, either in resting conditions or after challenge. Furthermore, corticosterone was a more consistent anti‐inflammatory agent than 17β‐estradiol in vitro. Our results support the hypothesis that adult microglia are a direct target of steroid hormones and that glucocorticoids, through the predominant expression of GR and MR, are the primary steroid hormone regulators of microglial inflammatory activity. The down‐regulation of steroid hormone receptors after LPS challenge may serve as a prerequisite to suppressing the anti‐inflammatory actions of endogenous steroid hormones on the immune system, and contribute to a sustained activation of microglia. © 2008 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1210/endo.131.3.1505471

Aloisi F, 2005, Neuroglia, 285

10.1002/(SICI)1096-9861(19980216)391:1<322::AID-CNE12>3.0.CO;2-U

10.1002/neu.1038

10.1210/en.2004-0619

10.1016/S0024-3205(01)01475-8

Belcher SM, 2001, Estrogenic actions in the brain: estrogen, phytoestrogens, and rapid intracellular signaling mechanisms, J Pharmacol Exp Ther, 299, 408

10.1016/0022-4731(88)90352-4

10.1016/0960-0760(91)90173-3

10.1210/endo.141.10.7693

10.1186/1742-2094-1-10

10.1016/S1474-4422(05)70220-9

10.1016/S1567-5769(01)00147-3

10.1046/j.1471-4159.2002.00799.x

Cohen JH, 1983, Sex steroid receptors in peripheral T cells: Absence of androgen receptors and restriction of estrogen receptors to OKT8‐positive cells, J Immunol, 131, 2767, 10.4049/jimmunol.131.6.2767

10.1210/jc.81.2.820

10.2174/1381612053381693

10.1016/0022-4731(86)90301-8

10.2741/1272

10.1016/j.jneuroim.2004.12.016

10.1046/j.1471-4159.2003.01604.x

10.1080/13550280290100914

10.1016/j.neuroscience.2005.06.020

10.1016/S0165-5728(03)00177-2

10.1016/j.brainresrev.2004.12.018

10.1002/cne.10325

10.1128/MCB.25.8.2957-2968.2005

10.4049/jimmunol.175.12.8303

10.1002/jlb.50.1.86

10.1016/j.neures.2005.12.012

10.1016/j.neuroscience.2005.12.046

10.1016/j.neurobiolaging.2004.12.006

10.1016/j.neuroscience.2005.06.050

10.1038/nri1602

10.1097/00024382-200115010-00005

10.1016/0165-3806(91)90191-K

10.1016/S0197-0186(02)00076-1

Lippman M, 1977, Glucocorticoid receptors in purified subpopulations of human peripheral blood lymphocytes, J Immunol, 118, 1977, 10.4049/jimmunol.118.6.1977

10.1002/jnr.20583

10.1016/0022-4731(87)90135-X

10.4049/jimmunol.175.8.5146

10.1002/cne.20724

10.1002/1096-9861(20010115)429:3<355::AID-CNE1>3.0.CO;2-#

10.1002/hipo.450020204

10.1210/en.2002-221069

10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C

10.1523/JNEUROSCI.23-13-05536.2003

10.1016/0889-1591(87)90018-3

10.2174/1568010042634460

10.1677/joe.0.1350333

10.1007/PL00000238

10.1002/hipo.10045

10.1113/expphysiol.2005.030734

10.1210/er.2005-0002

10.1182/blood-2002-02-0569

10.1016/0165-3806(91)90109-V

10.1016/j.tox.2004.04.015

10.1111/j.1365-2826.2004.01226.x

10.1002/glia.20468

10.1046/j.1460-9568.2003.02872.x

10.1002/cne.902940107

10.4049/jimmunol.174.10.6391

10.1677/joe.0.1690429

10.1016/j.tem.2004.01.005

10.1007/s00011-005-1343-z

10.1016/j.neulet.2004.07.042

10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.0.CO;2-6

10.1210/en.2006-0981

10.1002/cne.10753

10.1002/jnr.490210113

10.1073/pnas.1531957100

10.1210/en.2005-1330

10.1523/JNEUROSCI.21-06-01809.2001

10.1084/jem.147.6.1684

10.2144/05391RV01

10.1111/j.1399-6576.2004.00434.x